The FDA has approved Thermo Fisher’s Oncomine Dx Target Test, a next-generation sequencing based companion diagnostic, to ...
Researchers at Weill Cornell Medicine have made a breakthrough in the fight against liver cancer, by identifying a biomarker ...
The use of engineered viruses in cancer treatment is gaining significant traction, offering new avenues for enhancing immune ...
Sanofi and Orano Med have partnered to accelerate the development of next-generation radioligand therapies for rare cancers, ...
The FDA has approved zolbetuximab-clzb (VYLOY) as a first-line targeted therapy, in combination with chemotherapy, for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback